Moolec Science (MLEC) Operating Income (2022 - 2024)
Moolec Science's (MLEC) quarterly Operating Income came in at -$2.1 million in Q4 2024, down 14.86% year-on-year from -$2.4 million in Q1 2024, and up 2.0% quarter-over-quarter from -$2.1 million in Q3 2024.
Moolec Science (MLEC) Operating Income (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Operating Income across 3 years of filings, most recently posting -$2.1 million for Q4 2024.
- Operating Income for Q4 2024 came in at -$2.1 million, down 14.86% year-over-year; the trailing twelve-month figure through Dec 2024 was $19.2 million (down 79.84% YoY), and the FY2024 annual result was $19.3 million, down 80.33% from the prior year.
- Operating Income came in at -$2.1 million for Q4 2024 at Moolec Science, up from -$2.1 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $100.6 million in Q2 2023 to a low of -$2.3 million in Q3 2023.
- The 3-year median for Operating Income is -$1.0 million (2022), against an average of $12.2 million.
- Peak annual rise in Operating Income reached 196.44% in 2023, while the deepest fall reached 279.55% in 2023.
- Moolec Science's Operating Income stood at -$472416.0 in 2022, then tumbled by 279.55% to -$1.8 million in 2023, then retreated by 14.86% to -$2.1 million in 2024.
- The last three Operating Income figures came in at -$2.1 million (Q4 2024), -$2.1 million (Q3 2024), and $25.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | 25.39 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Dec 31, 2023 | -1.79 Mn |
| Sep 30, 2023 | -2.27 Mn |
| Jun 30, 2023 | 100.62 Mn |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | -472,416.00 |
| Sep 30, 2022 | -718,315.00 |
| Jun 30, 2022 | 33.94 Mn |
| Mar 31, 2022 | -519,962.00 |